Advanced cancer treatment often requires targeted biological therapies to improve survival and control disease progression. ABEVMY 400 Injection is a widely used monoclonal antibody therapy in oncology. At Unnati Pharmax, we are engaged in the global export of ABEVMY 400 from India, supplying quality-assured medicines with complete regulatory compliance.
This blog explains ABEVMY 400 uses, composition, mechanism of action, dosage, side effects, and export details.
What is ABEVMY 400?
ABEVMY 400 contains Bevacizumab, a monoclonal antibody that inhibits tumor blood vessel formation. By targeting vascular endothelial growth factor (VEGF), it helps slow the growth and spread of cancer.
Because of its targeted anti-angiogenic action, ABEVMY 400 is an important biologic therapy in modern oncology.
Uses of ABEVMY 400 Injection
ABEVMY 400 is commonly prescribed for the treatment of:
-
Colorectal cancer
-
Non-small cell lung cancer (NSCLC)
-
Ovarian cancer
-
Cervical cancer
-
Glioblastoma
-
Renal cell carcinoma
Therefore, ABEVMY 400 plays a vital role in the treatment of multiple solid tumors.
How Does ABEVMY 400 Work?
ABEVMY 400 blocks VEGF, which tumors need to form new blood vessels.
As a result:
-
Tumor blood supply is reduced
-
Cancer growth slows down
-
Spread of cancer cells is limited
This mechanism helps improve treatment outcomes when used alone or in combination with chemotherapy.
Dosage and Administration
-
Administered as an intravenous infusion
-
Dosage depends on cancer type, body weight, and treatment protocol
-
Given under strict medical supervision in a clinical setting
⚠️ Important: Dosage and treatment schedule must be determined by an oncologist.
Possible Side Effects
Some patients may experience:
-
High blood pressure
-
Fatigue
-
Bleeding complications
-
Protein in urine
-
Delayed wound healing
-
Diarrhea or abdominal pain
However, careful monitoring helps manage these effects effectively.
Precautions and Warnings
Patients should inform their doctor if they have:
-
Recent surgery or planned surgery
-
Uncontrolled hypertension
-
Bleeding disorders
-
Heart or kidney disease
-
Pregnancy or breastfeeding plans
Regular blood pressure and urine monitoring are recommended.
Why Choose Unnati Pharmax for ABEVMY 400 Export?
Unnati Pharmax is a reliable Indian pharmaceutical exporter, trusted by global partners.
Our Key Advantages
-
WHO-GMP compliant supply sources
-
Competitive export pricing
-
Cold-chain and export-standard packaging
-
Complete regulatory documentation
-
Reliable worldwide delivery
As a result, international buyers prefer Unnati Pharmax for oncology biologics.
Global Export of ABEVMY 400 Injection
Unnati Pharmax exports ABEVMY 400 to:
-
Africa
-
Middle East
-
Southeast Asia
-
CIS countries
-
Latin America
Additionally, we provide end-to-end logistics and documentation support.
Frequently Asked Questions (FAQs)
1. What is ABEVMY 400 used for?
ABEVMY 400 is used to treat various solid tumors including colorectal, lung, and ovarian cancers.
2. Is ABEVMY 400 chemotherapy?
No. ABEVMY 400 is a targeted monoclonal antibody therapy, not chemotherapy.
3. Can ABEVMY 400 be exported from India?
Yes. Unnati Pharmax exports ABEVMY 400 with full legal and regulatory compliance.
4. How should ABEVMY 400 be stored?
Store under recommended refrigerated conditions as per manufacturer guidelines.
5. Why source ABEVMY 400 from Unnati Pharmax?
Because we ensure authentic supply, regulatory support, and dependable global delivery.
Conclusion
In conclusion, ABEVMY 400 Injection is a highly effective biologic therapy used in the treatment of several advanced cancers. Choosing a trusted exporter is crucial for maintaining quality and treatment continuity.
